Follow
William Douglas Figg, Sr
William Douglas Figg, Sr
National Cancer Institute
Verified email at mail.nih.gov - Homepage
Title
Cited by
Cited by
Year
Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical …
HI Scher, S Halabi, I Tannock, M Morris, CN Sternberg, MA Carducci, ...
Journal of clinical oncology: official journal of the American Society of …, 2008
23722008
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group
GJ Bubley, M Carducci, W Dahut, N Dawson, D Daliani, M Eisenberger, ...
Journal of Clinical Oncology 17 (11), 3461-3467, 1999
11401999
Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma
RL Piekarz, R Frye, M Turner, JJ Wright, SL Allen, MH Kirschbaum, J Zain, ...
Journal of clinical oncology 27 (32), 5410, 2009
8452009
Thalidomide
ME Franks, GR Macpherson, WD Figg
The Lancet 363 (9423), 1802-1811, 2004
8362004
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
AG Duffy, SV Ulahannan, O Makorova-Rusher, O Rahma, H Wedemeyer, ...
Journal of hepatology 66 (3), 545-551, 2017
7612017
Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human …
KC Conlon, E Lugli, HC Welles, SA Rosenberg, AT Fojo, JC Morris, ...
Journal of clinical oncology 33 (1), 74, 2015
6882015
Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms
V Sandor, S Bakke, RW Robey, MH Kang, MV Blagosklonny, J Bender, ...
Clinical Cancer Research 8 (3), 718-728, 2002
6852002
Herbal remedies in the United States: potential adverse interactions with anticancer agents
A Sparreboom, MC Cox, MR Acharya, WD Figg
Journal of clinical oncology 22 (12), 2489-2503, 2004
6352004
Angiogenesis inhibitors: current strategies and future prospects
KM Cook, WD Figg
CA: a cancer journal for clinicians 60 (4), 222-243, 2010
6152010
Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas
HA Fine, WD Figg, K Jaeckle, PY Wen, AP Kyritsis, JS Loeffler, VA Levin, ...
Journal of Clinical Oncology 18 (4), 708-708, 2000
5872000
Comparative preclinical and clinical pharmacokinetics of a cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in Cremophor (Taxol)
A Sparreboom, CD Scripture, V Trieu, PJ Williams, T De, A Yang, B Beals, ...
Clinical cancer research 11 (11), 4136-4143, 2005
5742005
Effects of ligand activation of peroxisome proliferator-activated receptor γ in human prostate cancer
E Mueller, M Smith, P Sarraf, T Kroll, A Aiyer, DS Kaufman, W Oh, ...
Proceedings of the National Academy of Sciences 97 (20), 10990-10995, 2000
5542000
Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma
RL Piekarz, R Frye, HM Prince, MH Kirschbaum, J Zain, SL Allen, ES Jaffe, ...
Blood, The Journal of the American Society of Hematology 117 (22), 5827-5834, 2011
5362011
Antibody–drug conjugates for cancer
CH Chau, PS Steeg, WD Figg
The Lancet 394 (10200), 793-804, 2019
5132019
Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma
QC Ryan, D Headlee, M Acharya, A Sparreboom, JB Trepel, J Ye, ...
Journal of Clinical Oncology 23 (17), 3912-3922, 2005
4892005
Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms.
AM Senderowicz, D Headlee, SF Stinson, RM Lush, N Kalil, L Villalba, ...
Journal of Clinical Oncology 16 (9), 2986-2999, 1998
4861998
Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer.
A Thibault, D Samid, AC Tompkins, WD Figg, MR Cooper, RJ Hohl, ...
Clinical cancer research: an official journal of the American Association …, 1996
4801996
Drug interactions in cancer therapy
CD Scripture, WD Figg
Nature Reviews Cancer 6 (7), 546-558, 2006
4652006
Selumetinib in children with inoperable plexiform neurofibromas
AM Gross, PL Wolters, E Dombi, A Baldwin, P Whitcomb, MJ Fisher, ...
New England Journal of Medicine 382 (15), 1430-1442, 2020
4522020
Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer
WL Dahut, JL Gulley, PM Arlen, Y Liu, KM Fedenko, SM Steinberg, ...
Journal of clinical oncology 22 (13), 2532-2539, 2004
4522004
The system can't perform the operation now. Try again later.
Articles 1–20